How Much Did Oncora Raise?
Funding & Key Investors

Oncora, a company focused on cancer registry solutions, has secured significant enterprise-level funding, with its total funding reaching $2.5M. The company recently announced a major strategic investment of $1.3M, underscoring its growth trajectory and market position in the healthcare technology sector. This latest capital infusion is expected to fuel further development and expansion of its Cancer Registry Assistant.

What is Oncora?

Oncora
SoftwareHealthcare Software

Oncora Medical offers an intelligent Cancer Registry Assistant designed to enhance the quality control and efficiency of cancer data management within healthcare facilities and cancer registries. The platform aims to streamline operational processes, ensuring higher accuracy and adherence to best practices in cancer registry operations. By leveraging advanced technology, Oncora Medical supports organizations in maintaining robust cancer data standards, a critical component in cancer research and patient care.

How much funding has Oncora raised?

Oncora has raised a total of $2.5M across 2 funding rounds:

2016

Angel/Seed

$1.2M

2017

Unspecified

$1.3M

Angel/Seed (2016): $1.2M with participation from iSeed Ventures and BioAdvance

Unspecified (2017): $1.3M, investors not publicly disclosed

Key Investors in Oncora

iSeed Ventures

iSeed Ventures is a San Francisco-based venture capital firm that invests in innovative companies across various sectors, particularly those leveraging AI technology. With over $200 million under management, they seek to partner with pioneering leaders and provide strategic support throughout the growth phases of their portfolio companies.

BioAdvance

BioAdvance Capital is an investment firm focused on early-stage life-science companies in the Mid-Atlantic region, aiming to improve human health and quality of life. Their portfolio has successfully attracted over $4.4 billion in external capital to support the growth of its companies.

What's next for Oncora?

With the recent major strategic investment, Oncora is poised for significant expansion. The company's focus on improving cancer data management positions it well within the growing health-tech market. Future developments are likely to include enhancements to its AI-driven assistant, broader integration capabilities with existing healthcare IT systems, and potential expansion into new geographical markets. The enterprise-level funding suggests a strategic push towards scaling operations and solidifying its market leadership in cancer registry quality control solutions.

See full Oncora company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Software industry

Healthcare SoftwareSoftware
Customer Engagement PlatformsSoftwareMobile App Development
SoftwareStorage & System Management SoftwareBusiness ServicesSoftware TestingDocument Management
Legal SolutionsSoftware

Frequently Asked Questions Regarding Oncora Financial Insights

What are the most recent funding rounds that Oncora has completed, and what were the funding rounds?
Oncora has recently completed 2 funding rounds: Unspecified on Sep 17, 2017, Angel/Seed on Mar 9, 2016.
What is the total amount of funding Oncora has raised to date?
Oncora has raised a total of $2.5M in funding to date.
How many funding rounds has Oncora completed?
Oncora has completed 2 funding rounds.
How much funding did Oncora raise in its most recent funding round?
Oncora raised $1.3M in its most recent funding round.
Which was the largest funding round in Oncora's history?
The largest funding round in Oncora's history was $1.3M.
See more information about Oncora